Influence of the Brownie Breast Shield on the Dynamics of Milk Removal (BDM)

February 7, 2020 updated by: Medela AG

The purpose of this study is to investigate the efficacy of breast drainage of the healthy breast with the new Medela pump set breast shield (Brownie).

The objective of the study is to verify the Brownie breast shield to be non-inferior to the current PersonalFit breast shield in emptying the healthy lactating breast.

Study Overview

Status

Completed

Conditions

Detailed Description

In this study we could show that the Brownie shield is non-inferior to the PersonalFit shield in all four endpoints, superior to the PersonalFit shield in terms of PAMR and expressed milk volume, and is more comfortable than the PersonalFit shield according to participant surveys.

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zug
      • Baar, Zug, Switzerland, 6341
        • Medela AG

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Subject ≥ 18 years old
  2. Infant is ≥1 and ≤6 month old
  3. Subject is predominantly breastfeeding (80% of all feeds, i.e. ≤150 ml formula/day or equal representative amount of solid food)
  4. The subject agrees to pump or feed the last time a minimum of 3 hours before the start of the pumping session at the study site
  5. The subject agrees to photographs of the breast and upper body (no face)
  6. The subject agrees to perform a 24 hour milk production at home, inclusive weighing the Infant before and after each feeding
  7. The subject agrees to collect ~2 ml of milk before and after each feeding for fat analysis
  8. The subject signed the Informed Consent Form

Exclusion Criteria:

  1. Mastitis (any breast within two weeks prior enrolment)
  2. Engorgement (any breast within two weeks prior enrolment)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A

Drainage of the lactating breast using:

PersonalFit - Breast shield & Brownie - Breast shield

Breast shields are each to be used for 15 min pumping with the symphony breastpump

Subjects are to pump 15 min with the comparator device
Subjects are to pump 15 min with the investigational device
Experimental: Group B

Drainage of the lactating breast using:

Brownie - Breast shield & PersonalFit - Breast shield

Breast shields are each to be used for 15 min pumping with the symphony breastpump

Subjects are to pump 15 min with the comparator device
Subjects are to pump 15 min with the investigational device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PAMR
Time Frame: 7-21 days
Breast drainage, determined by the metric percent of available milk removed (PAMR).
7-21 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Milk volume
Time Frame: After 15 minutes of controlled pumping with the test or comparator device. Each participant will pump twice with a "washout period" of 7-21 days in between the corresponding occasions.
Expressed breast milk volume
After 15 minutes of controlled pumping with the test or comparator device. Each participant will pump twice with a "washout period" of 7-21 days in between the corresponding occasions.
Mid fat content
Time Frame: After 15 minutes of controlled pumping with the test or comparator device. Each participant will pump twice with a "washout period" of 7-21 days in between the corresponding occasions.
Breast milk - mid fat content
After 15 minutes of controlled pumping with the test or comparator device. Each participant will pump twice with a "washout period" of 7-21 days in between the corresponding occasions.
Hind fat content
Time Frame: After 15 minutes of controlled pumping with the test or comparator device. Each participant will pump twice with a "washout period" of 7-21 days in between the corresponding occasions.
Breast milk - hind fat content
After 15 minutes of controlled pumping with the test or comparator device. Each participant will pump twice with a "washout period" of 7-21 days in between the corresponding occasions.
Device usability
Time Frame: After 15 minutes of controlled pumping with the test or comparator device. Each participant will pump twice with a "washout period" of 7-21 days in between the corresponding occasions.
Device usability questionnaire
After 15 minutes of controlled pumping with the test or comparator device. Each participant will pump twice with a "washout period" of 7-21 days in between the corresponding occasions.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Lennart Ivarsson, PhD, Employee

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 31, 2017

Primary Completion (Actual)

September 30, 2017

Study Completion (Actual)

December 19, 2017

Study Registration Dates

First Submitted

March 15, 2017

First Submitted That Met QC Criteria

March 24, 2017

First Posted (Actual)

March 27, 2017

Study Record Updates

Last Update Posted (Actual)

February 10, 2020

Last Update Submitted That Met QC Criteria

February 7, 2020

Last Verified

February 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • MHM1601

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lactation

Clinical Trials on PersonalFit - Breast shield

Subscribe